Federal Trade Commission v. Phoebe Putney Health System, Inc.
The Supreme Court ruled that a Georgia hospital authority could not claim immunity from federal antitrust law when it bought the only other hospital in its county, because Georgia never clearly authorized hospital authorities to make anticompetitive acquisitions.
The decision limits how broadly local governments can use general grants of power -- like the power to buy and lease property -- to escape federal antitrust scrutiny, and sends the case back for the FTC's challenge to proceed.
How it got here: A federal trial court dismissed the FTC's suit on state-action immunity grounds; the Eleventh Circuit affirmed; the FTC asked the Supreme Court to review.
The Case in Depth
What happened
Georgia's Hospital Authorities Law lets local governments create hospital authorities with broad powers, including buying and leasing hospitals. A hospital authority in Albany, Georgia owned Memorial, one of only two hospitals in the county, and arranged to buy the other one, Palmyra, and lease it to a private nonprofit it controlled. The FTC said this would create a near-monopoly in local hospital services.
The question before the Court
Could a Georgia hospital authority buy up its only local competitor and claim immunity from federal antitrust law simply because state law let it acquire hospitals?
The Court's answer
No -- the Court ruled that the hospital authority could not claim state-action immunity, because Georgia never clearly said it wanted hospital authorities to use their acquisition powers to reduce competition. Under the Court's "clear articulation" test, a local government body escapes federal antitrust law only when the state has affirmatively and clearly signaled a policy to displace competition, not merely when the state gave the body ordinary business powers like buying and leasing property.
The Georgia law at issue gave hospital authorities general corporate powers that mirror what any private company can do, without saying anything about permitting mergers that substantially reduce competition. Because the anticompetitive effect here was not the inherent or foreseeable result of exercising those general powers, the immunity defense failed, and the FTC's challenge to the hospital purchase can go forward.
Curious how the Court got there? See the step-by-step legal reasoning →
Why it matters
Local government-created entities across the country -- not just hospital authorities -- often hold broad, generic powers to acquire and manage property. This ruling tells them that having such powers on the books doesn't shield anticompetitive mergers from federal antitrust review, making it easier for regulators like the FTC to challenge hospital and other public-entity mergers that reduce competition.
What changes now
The case returns to the lower courts, where the FTC's original antitrust challenge to the hospital purchase can proceed, since the transaction has already closed. The district court can still consider remedies to prevent respondents from taking further steps that would lock in the anticompetitive effects while the underlying antitrust claim is litigated. This is a final merits ruling on the immunity question, not an emergency or temporary order.
What this does not decide
The Court did not decide whether the hospital purchase actually violates antitrust law, only that the hospital authority could not claim immunity from having to defend against that claim. It also left unresolved whether a separate 'market participant' exception to immunity might apply, since that argument wasn't raised below.
How the Court got there
The legal reasoning, step by step
- The Court applied the two-part state-action immunity test, which asks first whether the challenged conduct was clearly articulated and affirmatively expressed as state policy, and second (for private actors) whether the state actively supervises it; local governmental entities need only satisfy the first part.
- Because state-action immunity is disfavored given the antitrust laws' commitment to free competition, the Court applies the clear-articulation test strictly: immunity attaches only when it is clear the state's own regulatory scheme -- not just neutral permission -- covers the anticompetitive conduct.
- The Court distinguished between general grants of power that entities can use in ordinary, competition-neutral ways (which do not show the state contemplated anticompetitive use) and grants of authority that are inherently or logically anticompetitive in their ordinary exercise (which do show the state foresaw and endorsed the anticompetitive effect), relying on its earlier decisions in Hallie and Omni for the second category.
- Measured against that distinction, Georgia's grant of power to hospital authorities to acquire, lease, and manage projects mirrors the general powers routinely given to ordinary private corporations, and using those powers to buy out a competitor is not their inherent or ordinary result.
- The Court rejected the Eleventh Circuit's looser 'foreseeability' approach, which asked only whether the legislature could have reasonably anticipated some anticompetitive effect, holding that this diluted the requirement that the state itself have affirmatively contemplated displacing competition.
- Because nothing in Georgia's law or its broader regulatory scheme for hospitals showed the state meant to let hospital authorities consolidate ownership of competing hospitals, the clear-articulation test was not satisfied and immunity did not apply.
Doctrinal impact
Cases affected by this decision
Reaffirms Community Communications Co. v. Boulder (455 U.S. 40)
The Court relied on Boulder's rule that mere neutral grants of power don't show a state intended anticompetitive conduct.
Reaffirms Hallie v. Eau Claire (471 U.S. 34)
The Court used Hallie's foreseeability principle but clarified it applies only to inherently anticompetitive grants of authority.
Reaffirms Parker v. Brown (317 U.S. 341)
The Court relied on Parker's foundational rule that antitrust laws don't bar states from acting as sovereigns.